The MHRA is encouraging patients, parents, carers, and healthcare professionals to report suspected side effects through the Yellow Card scheme as part of MedSafetyWeek 2026. This initiative aims to enhance patient safety by increasing awareness and participation in reporting adverse drug reactions.
By promoting the Yellow Card scheme, the MHRA seeks to gather more data on side effects, which could lead to improved drug safety monitoring. This may have implications for manufacturers and suppliers, as increased reporting could result in more rigorous scrutiny of drug safety profiles and potential regulatory actions.
Source: gov.uk · Image: Guantanamo Bay Hospital Promotes Patient Safety Culture (8940306) by U.S. Navy photo by Emily McCamy, Public domain, via Wikimedia Commons
Use the database as your supply chain compass →
